Is resveratrol a potential substitute for leuprolide acetate in experimental endometriosis?

@article{BayoluTekin2015IsRA,
  title={Is resveratrol a potential substitute for leuprolide acetate in experimental endometriosis?},
  author={Yeşim Bayoğlu Tekin and Suleyman Guven and Aynur Kırbaş and Yıldıray Kalkan and Levent Tumkaya and Emine Seda Guvendag Guven},
  journal={European journal of obstetrics, gynecology, and reproductive biology},
  year={2015},
  volume={184},
  pages={
          1-6
        }
}
OBJECTIVE Resveratrol, a phytoalexin polyphenol, has anti-angiogenic, antioxidant, anti-inflammatory properties. We aimed to compare the anti-inflammatory and anti-angiogenic effects of resveratrol and leuprolide acetate (LA) in an experimental endometriosis model. STUDY DESIGN A prospective experimental study was conducted in a University Surgical Research Center. Thirty-three non-pregnant female Sprague-Dawley rats, in which experimental model of endometriosis were surgically induced were… Expand
A randomized exploratory trial to assess the effects of resveratrol on VEGF and TNF-α 2 expression in endometriosis women.
TLDR
It seems resveratrol may improve the endometrium of endometriosis patients in window of implantation period by modifying the expression of VEGF and TNF-α but further investigations are needed to reveal the potential role of this compound. Expand
Euterpe oleracea Extract (Açaí) Is a Promising Novel Pharmacological Therapeutic Treatment for Experimental Endometriosis
TLDR
The results suggest that açaí effectively suppressed the establishment and growth of endometriotic lesions, and this agent is a promising novel pharmacological therapeutic treatment for endometRIosis. Expand
Resveratrol and endometriosis: In vitro and animal studies and underlying mechanisms (Review).
TLDR
In animal models of endometriosis, resveratrol supplementation has displayed beneficial results as it decreased the number and volume ofendometrial implants, suppressed proliferation, vascularization, inflammation, cell survival and increased apoptosis. Expand
Therapeutic Approaches of Resveratrol on Endometriosis via Anti-Inflammatory and Anti-Angiogenic Pathways
TLDR
From the studies reviewed in this paper, it is clear that the anti-inflammatory effect of this natural compound can contribute to the prevention of endometriosis, this phenolic compound now being considered a new innovative drug in the prevention and treatment of this disease. Expand
Transcriptome-Based Analysis Reveals Therapeutic Effects of Resveratrol on Endometriosis in aRat Model
TLDR
Transcriptional analysis showed that the effects of resveratrol on the endometriosis model rats were manifested by alterations in the PPAR, insulin resistance, MAPK and PI3K/Akt signaling pathways. Expand
Therapeutic effects of resveratrol in Escherichia coli-induced rat endometritis model
TLDR
According to the results of the current study, resveratrol was found to be effective in the treatment of endometritis with its antioxidant and anti-inflammatory functions. Expand
The modulating effects of Resveratrol on the expression of MMP-2 and MMP-9 in endometriosis women: a randomized exploratory trial
TLDR
It is shown that Resveratrol can modify the inflammation process in the endometrium of women with endometriosis at least in the level of MMP-2 and -9 expressions. Expand
Genistein modulates the estrogen receptor and suppresses angiogenesis and inflammation in the murine model of peritoneal endometriosis
TLDR
It was concluded that genistein is able to modulate estrogen receptor-α and estrogen receptor -β and inhibit the development of inflammation and angiogenesis in the murine model of peritoneal endometriosis, and can be a candidate in the treatment of endometRIosis. Expand
ALTERNATIVE METHODS OF TREATMENT OF ENDOMETRIOSIS: RESVERATROL AND ITS COMBINATION WITH HORMONOTHERAPY
TLDR
In vivo studies it has been established that resveratrol causes inhibition of angiogenesis, the induction of apoptosis, and also results to a decrease in the size of endometriotic implants. Expand
Anti-Angiogenic Alternative and Complementary Medicines for the Treatment of Endometriosis: A Review of Potential Molecular Mechanisms
TLDR
This review aims to describe natural products and compounds that suppress angiogenesis associated with endometriosis and to assess their diverse molecular mechanisms of action, and to focus on anti-angiogenic products and alternative and complementary medicines for the treatment of endometRIosis. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 28 REFERENCES
Resveratrol is a potent inhibitor of vascularization and cell proliferation in experimental endometriosis.
TLDR
Resveratrol inhibited angiogenesis in peritoneal and mesenteric endometriotic lesions, as indicated by a significantly reduced microvessel density when compared with controls, and represents a promising candidate therapy for future phytochemical treatment of endometRIosis. Expand
Natural therapies assessment for the treatment of endometriosis.
TLDR
The present findings are promising and will assist the development of novel natural treatments for endometriosis as two polyphenols with anticarcinogenic and antioxidant properties that have been proposed as natural therapies to treat endometRIosis. Expand
Regression of Endometrial Implants by Resveratrol in an Experimentally Induced Endometriosis Model in Rats
TLDR
Resveratrol appears to be effective on the development of endometriosis through its antiangiogenic and anti-inflammatory properties. Expand
Peroxisome proliferator-activated receptor-gamma induces regression of endometrial explants in a rat model of endometriosis.
TLDR
This animal model suggests that a thiazolidinedione drug may be helpful in women with endometriosis, and concludes that a PPAR-gamma ligand, ciglitazone, reduced the size of experimental endometiosis in the rat model of endometRIosis. Expand
Regression of endometrial explants in a rat model of endometriosis treated with the immune modulators loxoribine and levamisole.
TLDR
Loxoribine, a potent immunomodulatory drug, appeared to cause regression in both stromal and epithelium components in a rat model of endometriosis. Expand
Resveratrol Inhibits Development of Experimental Endometriosis In Vivo and Reduces Endometrial Stromal Cell Invasiveness In Vitro1
TLDR
Resveratrol inhibits development of endometriosis in the nude mouse and reduces invasiveness of HES cells, which may aid in the development of novel treatments of endometricriosis. Expand
Resveratrol prevents the development of abdominal aortic aneurysm through attenuation of inflammation, oxidative stress, and neovascularization.
TLDR
Treatment with resveratrol in mice prevented the development of CaCl(2)-induced abdominal aortic aneurysm, in association with reduced inflammation, oxidative stress, neoangiogenesis, and extracellular matrix disruption. Expand
Vascular endothelial growth factor (VEGF) in endometriosis.
TLDR
Similarities in VEGF content were observed in the glandular epithelium of the eutopic endometrium of women with endometriosis and red lesions, suggesting that endometiosis probably arises from the peritoneal seeding of viable endometrial cells during retrograde menstruation and that red lesions can be considered as the first stage of implantation. Expand
Studies on the surgical induction of endometriosis in the rat.
TLDR
The successful growth and development of surgically transplanted endometrial tissue in the rat offers a research model that can be used to study those aspects of endometriosis that cannot be adequately investigated in women. Expand
Immunobiology of endometriosis.
TLDR
A complex network of locally produced cytokines modulate the growth and inflammatory behavior of ectopic endometrial implants and contribute to the enhanced inflammatory reaction associated with endometriosis that subserves the survival of these lesions instead of leading to their demise. Expand
...
1
2
3
...